Creative Medical Technology Holdings Inc (CELZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98 | 89 | 304 | 14 | 222 |
| Receivables | N/A | 6 | 10 | 5 | N/A |
| TOTAL | $98 | $94 | $314 | $19 | $222 |
| Non-Current Assets | |||||
| Intangibles | 620 | 437 | 164 | 185 | 101 |
| TOTAL | $620 | $437 | $164 | $185 | $101 |
| Total Assets | $718 | $531 | $477 | $203 | $323 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 789 | 1,062 | 682 | 252 | N/A |
| Accounts payable and accrued liabilities | 351 | 321 | 332 | 238 | 66 |
| Accrued Expenses | 160 | 121 | 22 | 23 | 5 |
| Other current liabilities | 39,221 | 7,099 | 3,436 | 1,673 | 283 |
| TOTAL | $40,521 | $8,602 | $4,472 | $2,435 | $454 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 25 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 4 | 1 |
| TOTAL | $N/A | $N/A | $N/A | $4 | $26 |
| Total Liabilities | $40,521 | $8,602 | $4,472 | $2,439 | $480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,646 | 5,980 | 89,060 | 24,482 | 10,501 |
| Common Shares | 2 | 23 | 6 | 115 | 105 |
| Retained earnings | -61,890 | -25,565 | -17,081 | -3,426 | -767 |
| TOTAL | $-39,803 | $-8,072 | $-3,995 | $-2,236 | $-158 |
| Total Liabilities And Equity | $718 | $531 | $477 | $203 | $323 |